Product Information
BUSPIRONE HCL 7.5 MG TABLET is a generic product labeled by Apnar Pharma LP, priced at $0.1105 per EA under NDC 24689078501. Its NADAC has been published 199 times since Mar 3, 2021.
Strength
7.5 mg/1
Manufacturer
Apnar Pharma LPNDC
24689078501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
BUSPIRONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA209696On Market Since
6/17/2024
Price Statistics
The NADAC for BUSPIRONE HCL 7.5 MG TABLET has been published 199 times since Mar 3, 2021, and over the history we have for it it has declined 59.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.2986 (May 12, 2021) |
| All-time low | $0.1105 (Jun 17, 2026) |
| 52-week high | $0.1225 |
| 52-week low | $0.1105 |
| Median price | $0.1657 |
| Average price | $0.1776 |
| Largest weekly change | -15.3% (Dec 22, 2021) |
| Weeks tracked | 199 |
| Tracking since | Mar 3, 2021 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUSPIRONE HCL 7.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BUSPIRONE HCL 7.5 MG TABLET, manufactured by Apnar Pharma LP, is $0.1105 per EA (NDC 24689078501), effective Jun 24, 2026.
How has the price of BUSPIRONE HCL 7.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has declined 59.4%. It has been tracked across 199 weekly CMS publications since Mar 3, 2021.
What are the highest and lowest recorded NADAC prices for BUSPIRONE HCL 7.5 MG TABLET?
Since Mar 3, 2021, the NADAC for BUSPIRONE HCL 7.5 MG TABLET has ranged from a low of $0.1105 (Jun 17, 2026) to a high of $0.2986 (May 12, 2021), with a median of $0.1657 per EA.
Are there cheaper alternatives to BUSPIRONE HCL 7.5 MG TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUSPIRONE HCL 7.5 MG TABLET, is $0.1039 per EA — about 6% below BUSPIRONE HCL 7.5 MG TABLET.
Who manufactures BUSPIRONE HCL 7.5 MG TABLET?
BUSPIRONE HCL 7.5 MG TABLET (NDC 24689078501) is labeled by Apnar Pharma LP, and CMS classifies it as a generic product.
Related Drugs
Same classification